INR 58.74
(2.07%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 161.84 Million INR | -14.23% |
2022 | 188.69 Million INR | 8.99% |
2021 | 173.13 Million INR | 13.16% |
2020 | 153 Million INR | 8.18% |
2019 | 141.43 Million INR | 23.89% |
2018 | 114.15 Million INR | 9.84% |
2017 | 103.93 Million INR | 0.28% |
2016 | 103.63 Million INR | -6.34% |
2015 | 110.64 Million INR | 9.5% |
2014 | 101.05 Million INR | 13.92% |
2013 | 88.7 Million INR | 71.81% |
2012 | 51.62 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 44.9 Million INR | -8.8% |
2023 Q3 | 62.04 Million INR | 5.04% |
2023 Q4 | 49.23 Million INR | -20.65% |
2023 FY | 161.84 Million INR | -14.23% |
2023 Q1 | 58.47 Million INR | 225.89% |
2023 Q2 | 59.07 Million INR | 1.02% |
2022 Q4 | -46.44 Million INR | -158.93% |
2022 Q3 | 78.81 Million INR | -2.39% |
2022 Q2 | 80.74 Million INR | 6.83% |
2022 Q1 | 75.58 Million INR | 316.02% |
2022 FY | 188.69 Million INR | 8.99% |
2021 Q4 | -34.99 Million INR | -144.47% |
2021 Q1 | 49.26 Million INR | -8.53% |
2021 Q2 | 80.24 Million INR | 62.88% |
2021 Q3 | 78.67 Million INR | -1.96% |
2021 FY | 173.13 Million INR | 13.16% |
2020 Q2 | 70.44 Million INR | 0.0% |
2020 Q4 | 53.86 Million INR | 0.0% |
2020 Q3 | 53.86 Million INR | -23.54% |
2020 Q1 | 70.44 Million INR | 55.45% |
2020 FY | 153 Million INR | 8.18% |
2019 Q3 | 45.31 Million INR | 5.84% |
2019 Q1 | 42.81 Million INR | 0.94% |
2019 FY | 141.43 Million INR | 23.89% |
2019 Q4 | 45.31 Million INR | 0.0% |
2019 Q2 | 42.81 Million INR | 0.0% |
2018 Q4 | 42.41 Million INR | 0.0% |
2018 FY | 114.15 Million INR | 9.84% |
2018 Q3 | 42.41 Million INR | 27.37% |
2018 Q1 | 33.3 Million INR | -5.8% |
2018 Q2 | 33.3 Million INR | 0.0% |
2017 FY | 103.93 Million INR | 0.28% |
2017 Q1 | 34.15 Million INR | 0.0% |
2017 Q2 | 34.15 Million INR | 0.0% |
2017 Q3 | 35.35 Million INR | 3.51% |
2017 Q4 | 35.35 Million INR | 0.0% |
2016 FY | 103.63 Million INR | -6.34% |
2015 FY | 110.64 Million INR | 9.5% |
2014 FY | 101.05 Million INR | 13.92% |
2013 FY | 88.7 Million INR | 71.81% |
2012 FY | 51.62 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.895% |
NATCO Pharma Limited | 10.05 Billion INR | 98.391% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 88.463% |
Syncom Formulations (India) Limited | 942.39 Million INR | 82.826% |
Achyut Healthcare Limited | 1.6 Million INR | -9958.67% |
Ajanta Pharma Limited | 30.46 Billion INR | 99.469% |
Alkem Laboratories Limited | 32.83 Billion INR | 99.507% |
Alpa Laboratories Limited | 156.14 Million INR | -3.648% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 98.98% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 93.776% |
Aurobindo Pharma Limited | 39.23 Billion INR | 99.588% |
Bajaj HealthCare Limited | 985.34 Million INR | 83.575% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 88.596% |
Brooks Laboratories Limited | 51.18 Million INR | -216.225% |
Divi's Laboratories Limited | 14.17 Billion INR | 98.858% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.831% |
Eris Lifesciences Limited | 4.94 Billion INR | 96.726% |
FDC Limited | 5.34 Billion INR | 96.974% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 99.76% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 98.61% |
Granules India Limited | 7.18 Billion INR | 97.747% |
Gufic Biosciences Limited | 1.07 Billion INR | 84.983% |
Hester Biosciences Limited | 908.84 Million INR | 82.192% |
Indoco Remedies Limited | 4.74 Billion INR | 96.592% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 92.381% |
Ipca Laboratories Limited | 13.91 Billion INR | 98.837% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | 79.074% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -250.646% |
Lasa Supergenerics Limited | 291.17 Million INR | 44.417% |
Laurus Labs Limited | 3.01 Billion INR | 94.625% |
Lupin Limited | 95.67 Billion INR | 99.831% |
Mankind Pharma Limited | 23.15 Billion INR | 99.301% |
Medicamen Biotech Limited | 335.16 Million INR | 51.712% |
Megasoft Limited | 49.52 Million INR | -226.773% |
Piramal Pharma Limited | 19.91 Billion INR | 99.187% |
RPG Life Sciences Limited | 1.63 Billion INR | 90.104% |
Sigachi Industries Limited | 579.88 Million INR | 72.09% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 94.74% |
Unichem Laboratories Limited | 6.72 Billion INR | 97.594% |
Wanbury Limited | 1.16 Billion INR | 86.059% |
Windlas Biotech Limited | 1 Billion INR | 83.92% |
ZIM Laboratories Limited | 1.01 Billion INR | 84.024% |
Zydus Lifesciences Limited | 43.17 Billion INR | 99.625% |
Procter & Gamble Health Limited | 2.99 Billion INR | 94.597% |
Amrutanjan Health Care Limited | 1.09 Billion INR | 85.273% |
Bal Pharma Limited | 389.89 Million INR | 58.49% |
Strides Pharma Science Limited | 9.16 Billion INR | 98.234% |
Venus Remedies Limited | 1.91 Billion INR | 91.554% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 94.736% |
Nectar Lifesciences Limited | 625.55 Million INR | 74.128% |
Shilpa Medicare Limited | 2.18 Billion INR | 92.578% |
Aarti Drugs Limited | 1.16 Billion INR | 86.137% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 85.271% |
Suven Life Sciences Limited | 109.75 Million INR | -47.466% |
Ind-Swift Limited | 946.56 Million INR | 82.902% |
Valiant Laboratories Limited | 36.28 Million INR | -345.986% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 98.077% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 96.466% |
Themis Medicare Limited | 782.85 Million INR | 79.326% |
Hikal Limited | 2.48 Billion INR | 93.491% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 99.244% |
Sequent Scientific Limited | 2.9 Billion INR | 94.423% |
Novartis India Limited | 470.1 Million INR | 65.572% |
Wockhardt Limited | 6.4 Billion INR | 97.471% |
Jubilant Pharmova Limited | 14.45 Billion INR | 98.88% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -898.439% |
Neuland Laboratories Limited | 2.92 Billion INR | 94.476% |
Morepen Laboratories Limited | 1.98 Billion INR | 91.857% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 60.758% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | 76.064% |